BeStock  
Stocks › Biotechnology › INSM

Insmed INSM

US equityMarket cap rank #631Biotechnology
$141.33 −$3.13 (-2.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $142.81 +1.05%
Open$143.27
Prev close$144.46
Day range$140.99 – $150.00
Volume6.22M
Market cap$31.01B
P/E (TTM)–
Dividend yield–

INSM Stock News

Headlines matching Insmed or the INSM ticker, most recent first.

  • Barclays Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $207 NegativeMarket news · 30 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $175Market news · 28 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $188 NegativeMarket news · 24 Sep 2026 · Direct mention
  • Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195Market news · 23 Sep 2026 · Direct mention
  • BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $214Market news · 22 Sep 2026 · Direct mention
  • Roth MKM Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $198 NegativeMarket news · 15 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $218Market news · 13 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $170 to $237Market news · 8 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $169 to $243Market news · 7 Aug 2026 · Direct mention
  • BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $209 NegativeMarket news · 3 Aug 2026 · Direct mention
  • RBC Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $195Market news · 27 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Insmed(INSM.US) With Buy Rating, Raises Target Price to $195 PositiveMarket news · 25 Aug 2026 · Direct mention
  • BMO Capital Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $192Market news · 18 Aug 2026 · Direct mention
  • Truist Financial Maintains Insmed(INSM.US) With Buy Rating, Announces Target Price $195Market news · 10 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $175 NegativeMarket news · 10 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on INSM.

Sign in to join the discussion.

Scroll to Top